NASDAQ: NKTR NEKTAR THERAPEUTICS 8-K

Nektar completes $350.9M equity offering, selling 4.06M shares at $92 per share

Filed April 23, 2026 · Period ending April 21, 2026 · ~1 min read

Key Changes

  • high

    Nektar raised $350.9 million net proceeds by selling 4.06 million common shares at $92 each through an underwritten public offering that closed April 23, 2026. This represents approximately 4% dilution to existing shareholders.

    Item 1.01, 8.01 verify on EDGAR →
  • medium

    Underwriters (Jefferies, TD Securities, Piper Sandler) exercised their full over-allotment option to purchase an additional 529,891 shares, bringing total offering to 4.06M shares. Full greenshoe exercise typically signals strong investor demand.

  • high

    The offering was priced at $92 per share on April 21, 2026, with closing expected April 23, 2026. Net proceeds after underwriting fees and expenses total approximately $350.9 million.

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade NKTR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 5:31 PM